logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Kazuyoshi Shigehara

Kanazawa University
H指数:28
被引数:2,834

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Lowest PSA Level Achieved Before CRPC Predicts Abiraterone Response But Not Enzalutamide Response in Metastatic CRPC

在转移性CRPC中，达到CRPC前达到的最低PSA水平可预测阿比特龙的治疗反应，但不能预测恩扎卢amide的治疗反应

Prostate
IF2.5
2026-09-290
PRE
Kohei Hashimoto; Kouji Izumi; Takashi Shima; Yuki Kato; Koji Mita; Takehiko Okamura; Shogo Inoue; Shuichi Tatarano; Nobumichi Tanaka; Noriyasu Kawai; Manabu Kamiyama; Ippei Chikazawa; Seiji Hoshi; Takashi Fukagai; Kazuyoshi Shigehara; Shizuko Takahara; Atsushi Mizokami
Prognostic impact of diabetes or hypertension in smokers with CRPC receiving enzalutamide or abiraterone

吸烟的转移性去势抵抗性前列腺癌患者接受恩扎卢替尼或阿比特龙治疗时，糖尿病或高血压的预后影响

International Journal of Clinical Oncology
IF2.8
2026-09-190
PRE
Takashi Fukagai; Kouji Izumi; Motoki Yamagishi; Takashi Shima; Yuki Kato; Koji Mita; Takehiko Okamura; Shogo Inoue; Shuichi Tatarano; Nobumichi Tanaka; Noriyasu Kawai; Manabu Kamiyama; Ippei Chikazawa; Seiji Hoshi; Kohei Hashimoto; Kazuyoshi Shigehara; Shizuko Takahara; Atsushi Mizokami
Efficacy and Safety of Enzalutamide and Abiraterone in CRPC Patients With a History of Other Cancers: A Sub-Analysis of the ENABLE Study for PCa

恩扎卢替尼和阿比特龙在既往有其他癌症史的患者中的有效性和安全性：针对PCa的ENABLE研究的亚组分析

INTERNATIONAL JOURNAL OF UROLOGY
IF2.2
2026-05-201
PRE
Hoshi, Seiji; Izumi, Kouji; Meguro, Satoru; Shima, Takashi; Kato, Yuki; Mita, Koji; Okamura, Takehiko; Inoue, Shogo; Tatarano, Shuichi; Tanaka, Nobumichi; Yoshio, Yuko; Kamiyama, Manabu; Chikazawa, Ippei; Kawai, Noriyasu; Hashimoto, Kohei; Fukagai, Takashi; Shigehara, Kazuyoshi; Takahara, Shizuko; Mizokami, Atsushi
Fibroblast-mediated KRAS activation in double-negative prostate cancer

成纤维细胞介导的KRAS激活在双阴性前列腺癌中的作用

Cell Death & Disease
IF9.6
2026-05-020
OAAI
Taiki Kamijima; Kouji Izumi; Kaoru Hiratsuka; Takahiro Inaba; Yoshiki Koketsu; Ryunosuke Nakagawa; Ren Toriumi; Shuhei Aoyama; Hiroshi Kano; Tomoyuki Makino; Renato Naito; Suguru Kadomoto; Hiroaki Iwamoto; Hiroshi Yaegashi; Shohei Kawaguchi; Takahiro Nohara; Kazuyoshi Shigehara; Hiroki Nakata; Yohei Saito; Kyoko Nakagawa-Goto; Wen-Jye Lin; Atsushi Mizokami
High-Dose-Rate Brachytherapy Combined with External Beam Radiotherapy for Newly Defined Very High-Risk and Regional Prostate Cancer: A 17-Year Single-Institution Experience

高剂量率近距离治疗联合外照射放疗治疗新定义的极高危和区域前列腺癌：一项17年单机构经验

Cancers
IF4.4
2026-04-170
OA
Tomoyuki Makino; Takayuki Sakurai; Shigeyuki Takamatsu; Ryunosuke Nakagawa; Taiki Kamijima; Hiroshi Kano; Renato Naito; Hiroaki Iwamoto; Hiroshi Yaegashi; Kazuyoshi Shigehara; Takahiro Nohara; Kouji Izumi; Atsushi Mizokami
Dynamic Changes in Albumin and Systemic Immune-Inflammation Index as Prognostic Markers in Patients Treated with Cabozantinib After Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma

白蛋白和全身免疫炎症指数的动态变化作为接受免疫检查点抑制剂治疗后使用卡博赞尼治疗转移性肾细胞癌患者的预后标志物

Cancers 2025, Vol. 17, Page 3956
IF4.4
2025-12-110
OAAI
Rikushi Fujimura; Hiroshi Yaegashi; Ryunosuke Nakagawa; Taiki Kamijima; Hiroshi Kano; Tomoyuki Makino; Renato Naito; Suguru Kadomoto; Hiroaki Iwamoto; Kazuyoshi Shigehara; Takahiro Nohara; Kouji Izumi; Atsushi Mizokami
Real-World Efficacy of Postoperative Adjuvant Nivolumab in High-Risk Urothelial Carcinoma: A Retrospective Comparative Study in an Asian Population

高危尿路上皮癌术后辅助纳武利尤单抗的疗效：一项亚洲人群的回顾性比较研究

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
IF1.6
2025-11-010
PRE
Nakagawa, Ryunosuke; Naito, Renato; Izumi, Kouji; Inaba, Takahiro; Toriumi, Ren; Aoyama, Shuhei; Kamijima, Taiki; Kano, Hiroshi; Makino, Tomoyuki; Kadomoto, Suguru; Iwamoto, Hiroaki; Yaegashi, Hiroshi; Kawaguchi, Shohei; Nohara, Takahiro; Shigehara, Kazuyoshi; Mizokami, Atsushi
Seven-Year PSA ≤ 0.2 ng/mL After High-Dose-Rate Brachytherapy Indicates Eligibility for Discontinuing PSA Surveillance in Prostate Cancer

高强度率近距离放射治疗后七年内前列腺特异性抗原(PSA)≤0.2 ng/mL表明符合停止前列腺特异性抗原监测的条件，用于前列腺癌。

Cancers 2025, Vol. 17, Page 3151
IF4.4
2025-09-280
OAAI
Tomoyuki Makino; Takayuki Sakurai; Shigeyuki Takamatsu; Ryunosuke Nakagawa; Taiki Kamijima; Hiroshi Kano; Renato Naito; Hiroaki Iwamoto; Hiroshi Yaegashi; Kazuyoshi Shigehara; Takahiro Nohara; Kouji Izumi; Atsushi Mizokami
Androgen Receptor-Controlled microRNA-124-3p.2 Suppresses Prostate Cancer Progression via CCL2 Inhibition

雄激素受体调控的microRNA-124-3p.2通过抑制CCL2抑制前列腺癌进展。

Cancer Science
IF4.3
2025-07-220
OAAI
Shuhei Aoyama; Kouji Izumi; Kaoru Hiratsuka; Takahiro Inaba; Yoshiki Koketsu; Ryunosuke Nakagawa; Ren Toriumi; Taiki Kamijima; Hiroshi Kano; Tomoyuki Makino; Renato Naito; Suguru Kadomoto; Hiroaki Iwamoto; Hiroshi Yaegashi; Shohei Kawaguchi; Kazuyoshi Shigehara; Takahiro Nohara; Hiroki Nakata; Yohei Saito; Kyoko Nakagawa-Goto; Wen-Jye Lin; Atsushi Mizokami
Tumor-associated macrophages promote bladder cancer metastasis through the CCL20-CCR6 axis

肿瘤相关巨噬细胞通过CCL20-CCR6轴促进膀胱癌转移

NEOPLASIA
IF7.7
2025-02-010
OAAI
Nakagawa, Ryunosuke; Izumi, Kouji; Hiratsuka, Kaoru; Inaba, Takahiro; Koketsu, Yoshiki; Toriumi, Ren; Aoyama, Shuhei; Kamijima, Taiki; Kano, Hiroshi; Makino, Tomoyuki; Naito, Renato; Kadomoto, Suguru; Iwamoto, Hiroaki; Yaegashi, Hiroshi; Kawaguchi, Shohei; Nohara, Takahiro; Shigehara, Kazuyoshi; Nakata, Hiroki; Lin, Wen-Jye; Mizokami, Atsushi

研究方向

暂未获取到该数据
A
Atsushi Mizokami
H 指数:55论文数:575被引数:1.2万
K
Kouji Izumi
H 指数:34论文数:317被引数:5,725
T
Takahiro Nohara
H 指数:19论文数:161被引数:1,614
H
Hiroaki Iwamoto
H 指数:28论文数:179被引数:2,614
H
Hiroshi Yaegashi
H 指数:25论文数:227被引数:2,784
S
Shohei Kawaguchi
H 指数:16论文数:130被引数:1,022
Y
Yoshifumi Kadono
H 指数:28论文数:212被引数:2,557
S
Suguru Kadomoto
H 指数:16论文数:89被引数:1,823
H
Hiroshi Kano
H 指数:24论文数:131被引数:2,769
T
Tomoyuki Makino
H 指数:35论文数:186被引数:6,866